A multicenter Phase II study of Tislelizumab in combination with bevacizumab and chemotherapy in second-line RAS mutated metastatic colorectal cancer
收藏NIAID Data Ecosystem2026-03-13 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/41827
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: 1:Tislelizumab;1:Bevacizumab;1:mFOLFOX6;1:FOLFIRI
Primary outcome(s): safety;Objective response rate
Study Design: Single arm
创建时间：
2022-08-15
